The global prevalence of Helicobacter pylori (H. pylori) infection remains high, indicating a
persistent presence of this pathogenic bacterium capable of infecting humans. This review …

Helicobacter pylori (H. pylori) is the main cause of gastric adenocarcinoma. However, the
traditional antibiotic treatment of H. pylori is limited due to increased antibiotic resistance …

Helicobacter pylori is a pathogenic microorganism that mainly resides in the human stomach
and is the major cause of chronic gastritis, peptic ulcer and gastric cancer. Up to now, the …

Helicobacter pylori infection (Hp-I) represents a typical microbial agent intervening in the
complex mechanisms of gastric homeostasis by disturbing the balance between the host …

Gastric cancer (GC) is a leading type of cancer. Although immunotherapy has yielded
important recent progress in the treatment of GC, the prognosis remains poor due to drug …

Cancer is the second most common cause of death among humans in the world, and the
threat that it presents to human health is becoming more and more serious. The …

It has been about a century since the discovery of the first antibiotic, and during this period,
several antibiotics were produced and marketed. The production of high-potency antibiotics …

The biofilm community of microorganisms has been identified as the dominant mode of
microbial growth in nature and a common characteristic of different microorganisms such as …

Gut dysbiosis is observed in Alzheimer's disease (AD) and is frequently associated with AD-
induced metabolic dysfunction. However, the extent and specific underlying molecular …

Biofilm formation is one of the most important factors causing drug resistance of Helicobacter
pylori. Therefore, it is necessary to explore the mechanism underlying the biofilm formation …